News Home

Press Releases


Downloads
TIMELINE OF INNOVATION
CORPORATE FACT SHEET


Media Contacts

  • Jocelyn Polk, Associate Director,
    Corporate Communications
    978-671-8854
  • Michele Rozen
    Pure Communications
    617-730-8284

Recent Press Releases

6/14/09 SCIENTISTS WHO MADE SIGNIFICANT CONTRIBUTION TO DISCOVERY OF LANTHEUS MEDICAL IMAGING’S CARDIOLITE® HONORED WITH PRESTIGIOUS NUCLEAR MEDICINE AWARD AT SNM ANNUAL MEETING
6/13/09 LANTHEUS MEDICAL IMAGING, INC. TO RECEIVE LEU-DERIVED MO-99 FROM AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (ANSTO) AND BECOMES FIRST TO SUPPLY U.S. MARKET
6/12/09 BARI 2D STUDY PRESENTED AT AMERICAN DIABETES ASSOCIATION
SCIENTIFIC SESSIONS UNDERSCORES UTILITY OF SPECT MYOCARDIAL
PERFUSION IMAGING IN IDENTIFYING CARDIOVASCULAR RISK AND
EVALUATING TREATMENT OUTCOMES FOR PATIENTS WITH TYPE 2 DIABETES
6/04/09 SPECT MPI WITH CARDIOLITE® USED IN BARI 2D STUDY TO EVALUATE TYPE 2 DIABETES AND CORONARY ARTERY DISEASE TREATMENT STRATEGIES

© 2009 Lantheus Medical Imaging, Inc.

Use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.
Cardiolite® and DEFINITY® are registered trademarks of Lantheus Medical Imaging, Inc.
Any unlicensed use of these trademarks is expressly prohibited under the U.S. Trademark Act.
Intended for U.S. Residents Only